The goal of ProteinExpress, an R & D oriented company, is to become an important base for proteomics and, as its core business, conduct drug discovery research in the post-genome era. This is possible by making the best use of its fully comprehensive protein expression technology.

ProteinExpress focuses its business on exploring and validating seeds of novel drugs as a genome-based drug discovery company. Our business is based on recombinant DNA technology for effective protein production.

Genome-based Drug Seed Development Projects

Genome-based Drug Discovery Project
- Targeting genes for drug discovery
- Identifying target proteins by proteomics
- Validating drug seeds
KIAA Project
- Producing antibodies as a proteome analysis tool
- Proteomics with the utilization of antibodies